(T 97) From Feasibility Outcomes to Pivotal Study Design: The First FDA IDE-Approved Implantable Neuromodulation Trial in Resistant Migraine

Presenting Author(s)

Amaal J. J. Starling, MD

Associate Professor of Neurology
Mayo Clinic Arizona
Scottsdale, Arizona, United States

MM

Manjit Matharu, n/a

Professor of Neurology
UCL Queen Square Institute of Neurology, Headache and Facial Pain Group,
London, England, United States
Hsiangkuo Yuan, MD, PhD, FAHS

Associate Professor, Director of Clinical Research, Department of Neurology
Jefferson Headache Center
Penllyn, Pennsylvania, United States
RD

Robert Dworkin, PhD

University of Rochester School of Medicine and Dentistry, United States
Luana Colloca, MD, PhD

Interim Chair and Distinguished Professor
University of Maryland
Baltimore, Maryland, United States
RD

Roni Diaz, n/a

Salvia BioElectronics, United States
WP

Wim Pollet, MD

Salvia BioElectronics, United States
TS

Todd J. Schwedt, MD

Professor of Neurology
Mayo Clinic Arizona
Phoenix, Arizona, United States
UB

Ulrike Bingel, MD

University of Essen, United States